APA (7th ed.) Citation

Valikhani, A., Poopak, B., Ferdowsi, S., Azizi Tabesh, G., Ghaffari, S. H., Saraf Kazeruoni, E., . . . Amirizadeh, N. (2017). ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia. Asia Pacific Journal of Clinical Oncology, 13(2), e41. https://doi.org/10.1111/ajco.12588

Chicago Style (17th ed.) Citation

Valikhani, Amir, Behzad Poopak, Shirin Ferdowsi, Ghasem Azizi Tabesh, Seyed H. Ghaffari, Ehsan Saraf Kazeruoni, Negar Rezaei, Alireza Farshchi, and Naser Amirizadeh. "ASXL1 and JAK2V617F Gene Mutation Screening in Iranian Patients with Chronic Myeloid Leukemia." Asia Pacific Journal of Clinical Oncology 13, no. 2 (2017): e41. https://doi.org/10.1111/ajco.12588.

MLA (9th ed.) Citation

Valikhani, Amir, et al. "ASXL1 and JAK2V617F Gene Mutation Screening in Iranian Patients with Chronic Myeloid Leukemia." Asia Pacific Journal of Clinical Oncology, vol. 13, no. 2, 2017, p. e41, https://doi.org/10.1111/ajco.12588.